Surfactant protein B expression in bronchoalveolar lavage fluid of full-term neonates with respiratory distress syndrome

Acta Clinica Croatica

Volumn 53, Issue 2, 2014, Pages 161-165

  Yin, Xiaojuan ^a   Xie, Lu ^a   Chai, Yannan ^a   Fan, Hanxiao ^a   Han, Xiao ^a   Feng, Zhichun ^a  

^a Beijing Military Region General Hospital   (China)

Author keywords

Pulmonary surfactant associated protein B; Pulmonary surfactants; Respiratory distress syndrome, newborn

Indexed keywords

SURFACTANT PROTEIN B;

ARTICLE; ARTIFICIAL VENTILATION; BRONCHOALVEOLAR LAVAGE FLUID; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; THORAX RADIOGRAPHY; BLOOD GAS ANALYSIS; CASE CONTROL STUDY; CHEMISTRY; GESTATIONAL AGE; LUNG LAVAGE; METABOLISM; MORTALITY;

BLOOD GAS ANALYSIS; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MALE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 84907048255     PISSN: 03539466     EISSN: 13339451     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Nkadi PO, Merritt TA, Pillers DA. An overview of pulmonary surfactant in the neonate: genetics, metabolism, and the role of surfactant in health and disease. Mol Genet Metab 2009;97:97-95.
2. Shao XM, Ye HM, Qiu XX. Practical neonatology. Beijing:People's Health Publishing House, 2011.
3. Yin XJ, Xie L, Chi JH, Zheng Y, Xiong SH, Feng ZC. Neonatal respiratory distress syndrome in full-term neonates due to genetic SP-B defect: a report of 3 cases. Chin J Neonatol 2011;26:26.
4. Whitsett JA, Wert SE, Trap nell BC. Genetic disorders influencing lung formation and function at birth. Hum Mol Genet 2004;13 Spec No. 2:R207-215.
5. Perez-Gil J. Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions. Biochim Biophys Acta 2008;1778:1778-1676.
6. Mulugeta S, Beers MF. Surfactant protein C: its unique properties and emerging immunomodulatory role in the lung. Microbes Infect 2006;8:8-2317.
7. Iwanicki JL, Lu KW, Taeusch HW. Reductions of phospholipase A(2) inhibition of pulmonary surfactant with hyaluronan. Exp Lung Res 2010;36:36-167.
8. Greene KE, Wright JR, Steinberg KP, Ruzinski JT, Caldwell E, Wong WB, Hull W, Whitsett JA, Akino T, Kurok i Y, Nagae H, Hudson LD, Martin TR. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARD S. Am J Respir Crit Care Med 1999;160:160-1843.
9. Spragg RG, Lewis JF, Walmrath HD, Johannigman J, Bellingan G, Laterre PF, Witte MC, Richards GA, Rippin G, Rathgeb F, Hafner D, Taut FJ, Seeger W. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 2004;351:351-884.
10. Willson DF, Thomas NJ, Markovitz BP, Bauman LA, DiCarlo JV, Pon S, Jacobs BR, Jefferson LS, Conaway MR, Egan EA. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA 2005;293:293-470.
11. Faro A, Hamvas A. Lung transplantation for inherited disorders of surfactant metabolism. NeoReviews 2008;9:e468-e476.